-
-
Most postmenopausal women who suffer a fracture do not receive treatment for osteoporosis.
-
The FDA has approved the first drug for the treatment of moderate-to-severe Alzheimers disease. Memantine, a noncompetitive inhibitor of the N-methyl-D-aspartate receptor, has been available outside of the United States since 1982.
-
Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis; Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis; Exercise Testing to Predict Cardiovascular and All-Cause Death in Women
-
Exercise reduces the risk of breast cancer after menopause. Although the exercise need not be strenuous, longer duration of exercise confers greater benefit.
-
Treatment of CAP with 750 mg of levofloxacin daily for 5 days was as effective as a 10-day course of 500 mg daily.
-
The 12-lead ECG and accompanying lead II rhythm strip in the Figure were obtained from a 74-year-old man with sever pulmonary disease. The computer interpreted this tracing as showing normal sinus rhythm. Do you agree?
-
-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-
In this randomized control trial, Schneiderman and Associates evaluated the effect of an intervention, namely, an ethics consultation, on several variables associated with the care of patients eventually dying in the ICU.